Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10595-10603
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10595
Baseline | Remimazolam group (n = 40) | Propofol group (n = 40) | t/χ2 value | P value |
Age (yr) | 54.9 ± 8.5 | 52.7 ± 7.0 | 1.264 | 0.210 |
BMI (kg/m2) | 24.1 ± 2.4 | 23.9 ± 2.2 | 0.389 | 0.699 |
Systolic blood pressure (mmHg) | 126.3 ± 6.3 | 124.8 ± 8.1 | 0.925 | 0.358 |
Diastolic blood pressure (mmHg) | 75.7 ± 6.0 | 76.5 ± 7.3 | -0.535 | 0.594 |
Heart rate (times/min) | 76.7 ± 7.1 | 78.2 ± 7.7 | -0.906 | 0.368 |
Blood glucose (mmol/L) | 5.39 ± 0.51 | 5.50 ± 0.48 | -0.993 | 0.324 |
Gender, n (%) | 1.270 | 0.260 | ||
Male | 25 (62.50) | 20 (50.00) | ||
Female | 15 (37.50) | 20 (50.00) | ||
ASA grades, n (%) | 1.868 | 0.393 | ||
Grade I | 8 (20.00) | 6 (15.00) | ||
Grade II | 20 (50.00) | 26 (65.00) | ||
Grade III | 12 (30.00) | 8 (20.00) |
- Citation: Tang F, Yi JM, Gong HY, Lu ZY, Chen J, Fang B, Chen C, Liu ZY. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases 2021; 9(34): 10595-10603
- URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10595.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10595